Peptide Price Finder

Home · Clinical trials

Melanotan II clinical trials

ClinicalTrials.gov lists 1 registered trial of Melanotan II: 1 recruiting or about to, 0 running, 0 completed. Recruiting sites are in China. The largest is Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo (60 people).

1registered trials

1recruiting now

0running

0completed

0in phase 3

0with results posted

Recruiting: 11trials
  • Recruiting 1

Where Melanotan II is in testing

Registered trials by phase. Phase 3 trials are the large ones that decide approval.

0Early phase 1First doses in people
0Phase 1Safety and dosing
1Phase 2Does it work?
0Phase 3Large confirmatory trials
0Phase 4After approval
0Not phasedObservational and other

Timeline

Each bar runs from a trial's start to its planned end; faded bars have no end date. Click a bar to open the trial.

202620272028Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo · Recruiting · Phase 2 · 60 people · 2026-02-02 to 2027-02-14
RecruitingRunningCompletedStopped or withdrawnStatus unknownToday

Where trials are recruiting

Countries with sites in trials that are recruiting now.

Recruiting now 1

Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

RecruitingPhase 260 peopleRandomizedHudson Biotech2026-02-02 → 2027-02-14🇨🇳 China

Studying: NonSegmental Vitiligo, Nonsegmental Vitiligo (Stable) · NCT07437560

About this trial

This example interventional study record describes a randomized Phase 2 clinical trial evaluating investigational Melanotan II (MT-II) as an adjunct to standard NB-UVB phototherapy for repigmentation in adults with stable nonsegmental vitiligo.

Registered trials include ones that haven't published results yet. Trials are matched on the compound's name and code names (Melanotan II, melanotan-II, melanotan 2) in the listed interventions.